Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (30) Cervical Cancer
...CenterWatch: Clinical Trials in Category (30) Cervical Cancer Cervical Cancer State • California • Georgia • New York • Pennsylvania • Virginia Country • [X]   Philippines • [X]   Thailand California ...
View Page

2.  Study Posting (2246) Trial #106975, Cervical Cancer, Duarte, CA
...Study Posting (2246) Trial #106975, Cervical Cancer, Duarte, CA Trial Information Cervical Cancer Survivorship among African American and Latina Survivors You have ...
View Page

3.  Study Posting (2299) Trial #107390, Cervical Cancer, Rolling Hills Estates, CA
...Study Posting (2299) Trial #107390, Cervical Cancer, Rolling Hills Estates, CA Trial Information HPV Cervical Cancer Vaccine Study Worldwide, cervical cancer is ...
View Page

4. Clinical Trial Results: Cervical Cancer
...Clinical Trial Results: Cervical Cancer Clinical Trial Results: Cervical Cancer Product Name: Xeloda [capecitabine] Date of Report: To be Published ...
View Page

5.  CenterWatch: Clinical Trials in Category (421) Human Papilloma Virus (HPV)
...the Cobas® 4800 HPV Test in Identifying High-Grade Cervical Disease in Women Undergoing Routine Cervical Cancer Screening. Hoover : Research Site: A Study Evaluating the Performance of the Cobas® 4800 HPV Test ...
View Page

6.  Study Posting (713) Trial #154278, Cervical Cancer, Charlottesville, VA
...Study Posting (713) Trial #154278, Cervical Cancer, Charlottesville, VA Trial Information Women 18 yrs and older with Locally Advanced or Metastatic Cervical ...
View Page

7.  Study Posting (1082) Trial #66150, Human Papilloma Virus (HPV), Philadelphia, PA
...Study Posting (1082) Trial #66150, Human Papilloma Virus (HPV), Philadelphia, PA Trial Information Cervical cancer? Each year over 500,000 women around the world are diagnosed with cervical cancer. Philadelphia ...
View Page

8.  Study Posting (2299) Trial #107389, Human Papilloma Virus (HPV), Rolling Hills Estates, CA
...Posting (2299) Trial #107389, Human Papilloma Virus (HPV), Rolling Hills Estates, CA Trial Information HPV Cervical Cancer Vaccine Study Worldwide, cervical cancer is the fifth most common cause of death from cancer ...
View Page

9.  Study Posting (4519) Trial #101036, Cervical Cancer, Chiang Mai, Thailand
...Study Posting (4519) Trial #101036, Cervical Cancer, Chiang Mai, Thailand Trial Information A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With ...
View Page

10.  Study Posting (4519) Trial #100170, Cervical Cancer, Bangkok, Thailand
...Study Posting (4519) Trial #100170, Cervical Cancer, Bangkok, Thailand Trial Information A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Locally ...
View Page

11.  Study Posting (4519) Trial #105032, Cervical Cancer, Manila, Philippines
...Study Posting (4519) Trial #105032, Cervical Cancer, Manila, Philippines Trial Information A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Locally ...
View Page

12.  Study Posting (503) Trial #35913, Cervical Cancer, Pittsburgh, PA
...Study Posting (503) Trial #35913, Cervical Cancer, Pittsburgh, PA Trial Information Primary Physicians Research conducts a variety of studies concerning women's ...
View Page

13.  Study Posting (4519) Trial #101253, Anemia, Plymouth, United Kingdom
...Kingdom Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

14.  Study Posting (4519) Trial #101840, Anemia, Nottingham, United Kingdom
...Kingdom Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

15.  Study Posting (4519) Trial #99645, Anemia, Glasgow, United Kingdom
...Kingdom Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

16.  Study Posting (4519) Trial #99631, Anemia, Bristol, United Kingdom
...Kingdom Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

17.  Study Posting (4519) Trial #105430, Anemia, Izmir, Turkey
...Turkey Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

18.  Study Posting (4519) Trial #105417, Anemia, Istanbul, Turkey
...Turkey Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

19.  Study Posting (4519) Trial #105355, Anemia, Ankara, Turkey
...Turkey Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page

20.  Study Posting (4519) Trial #101044, Anemia, Chiang Mai, Thailand
...Thailand Trial Information (MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer Status: Completed Protocol Number: MO16375 Sponsor: Hoffmann-La Roche AG Company Division: Pharmaceutical Official Scientific ...
View Page